Accordingly, patients with inflammatory bowel disease (IBD) receiving an anti-TNF treatment had a 78% reduction in the incidence of PD compared to IBD patients who did not receive this therapy (112). The gene discussed is TNF; the disease is inflammatory bowel disease.